Evidence map›Paper›PMID 27733286›Full record

ArticleLancet (London, England)2016

Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

GBD 2015 Maternal Mortality Collaborators

Erratum issued 4 registry-linked trialsOpen access · hybridAbstract readComment
In one paragraph

Article in Lancet (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 4 registered trials, which are not on this map. Cited by 579 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
579citing papers in PubMed, 7 pooled it
185.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03856164 phase2 / phase3completednot on this mapstarted 2019, after this paper: background citation

Use of Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery

TypeinterventionalSponsorUniversity of Texas Southwestern Medical CenterRan2019 to 2020Enrolled110ConditionsPost Partum Hemorrhage, Fibrinolysis, Hemorrhage, Blood LossArmsTranexamic Acid, Placebo
NCT04632264 nacompletednot on this mapstarted 2020, after this paper: background citation

Optimal Timing of Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping - PROCEEDING (PostpaRtum OxytoCin Era dElayed corD clampING) Study

TypeinterventionalSponsorColumbia UniversityRan2020 to 2021Enrolled104ConditionsPostpartum HemorrhageArmsInitiation of standard postpartum oxytocin immediately following fetal shoulder delivery, Initiation of standard postpartum oxytocin immediately following placenta delivery, Saline Placebo
NCT05348980 phase4completednot on this mapstarted 2020, after this paper: background citation

Comparison of Two Different Doses of Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension During Cesarean Section: A Prospective Randomized Double-blinded Parallel Study

TypeinterventionalSponsorRehman Medical Institute - RMIRan2020 to 2020Enrolled60ConditionsHypotension, AnesthesiaArmsPhenylephrine Hydrochloride 4 mg, Phenylephrine Hydrochloride 8 mg
NCT06481995 phase4recruitingnot on this mapstarted 2024, after this paper: background citation

Early Factor XIII Replacement in Postpartum Hemorrhage: Multi-center, Randomized, Controlled, Investigator-initiated Trial

TypeinterventionalSponsorChristian HaslingerRan2024 to 2028Enrolled988ConditionsPostpartum Hemorrhage, Coagulation Disorder, Coagulation Factor Deficiency, HemorrhageArmsFibrogammin
3 · Its place in the literature

Who cites it

579 citing papers in PubMed, 7 syntheses or guidelines pooled it, 1,174 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Characteristics of longitudinal maternal health studies in sub-Saharan Africa: A systematic mapping of literature between 2012 and 2022.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Pooled it
  5. Pooled it
  6. Fetal Macrosomia and Postpartum Hemorrhage in Latin American and Caribbean Region: Systematic Review and Meta-analysis.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2023
    Pooled it
  7. Pooled it
  8. Trial
  9. Aspirin, Birthweight, and Large-For-Gestational-Age Neonates: A Secondary Analysis of the ASPRE Trial.BJOG : an international journal of obstetrics and gynaecology · 2025
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Humans are not unique: difficult birth is common in placental mammals.Biological reviews of the Cambridge Philosophical Society · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

519 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

GBD 2015 Maternal Mortality Collaborators
University of Washington · US

Funding

Department of Health RP-PG-0407-10184Medical Research Council G0400491Medical Research Council MC_U147585819Medical Research Council MC_U147585824Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UU_12011/1Wellcome Trust 096735/A/11/ZWellcome Trust 201900
6 · The paper itself

Abstract

backgroundIn transitioning from the Millennium Development Goal to the Sustainable Development Goal era, it is imperative to comprehensively assess progress toward reducing maternal mortality to identify areas of success, remaining challenges, and frame policy discussions. We aimed to quantify maternal mortality throughout the world by underlying cause and age from 1990 to 2015.

methodsWe estimated maternal mortality at the global, regional, and national levels from 1990 to 2015 for ages 10-54 years by systematically compiling and processing all available data sources from 186 of 195 countries and territories, 11 of which were analysed at the subnational level. We quantified eight underlying causes of maternal death and four timing categories, improving estimation methods since GBD 2013 for adult all-cause mortality, HIV-related maternal mortality, and late maternal death. Secondary analyses then allowed systematic examination of drivers of trends, including the relation between maternal mortality and coverage of specific reproductive health-care services as well as assessment of observed versus expected maternal mortality as a function of Socio-demographic Index (SDI), a summary indicator derived from measures of income per capita, educational attainment, and fertility.

findingsOnly ten countries achieved MDG 5, but 122 of 195 countries have already met SDG 3.1. Geographical disparities widened between 1990 and 2015 and, in 2015, 24 countries still had a maternal mortality ratio greater than 400. The proportion of all maternal deaths occurring in the bottom two SDI quintiles, where haemorrhage is the dominant cause of maternal death, increased from roughly 68% in 1990 to more than 80% in 2015. The middle SDI quintile improved the most from 1990 to 2015, but also has the most complicated causal profile. Maternal mortality in the highest SDI quintile is mostly due to other direct maternal disorders, indirect maternal disorders, and abortion, ectopic pregnancy, and/or miscarriage. Historical patterns suggest achievement of SDG 3.1 will require 91% coverage of one antenatal care visit, 78% of four antenatal care visits, 81% of in-facility delivery, and 87% of skilled birth attendance.

interpretationSeveral challenges to improving reproductive health lie ahead in the SDG era. Countries should establish or renew systems for collection and timely dissemination of health data; expand coverage and improve quality of family planning services, including access to contraception and safe abortion to address high adolescent fertility; invest in improving health system capacity, including coverage of routine reproductive health care and of more advanced obstetric care-including EmOC; adapt health systems and data collection systems to monitor and reverse the increase in indirect, other direct, and late maternal deaths, especially in high SDI locations; and examine their own performance with respect to their SDI level, using that information to formulate strategies to improve performance and ensure optimum reproductive health of their population.

fundingBill & Melinda Gates Foundation.

Indexed as

Prenatal CareFamily Planning ServicesGlobal HealthHumansMaternal MortalityParturitionReproductive Health

Identifiers

PMID27733286
PMCPMC5224694
OpenAlexW2529846601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.